Chiralix 2015
简要描述：Chiralix代理，Chiralix中国代理，Chiralix上海代理，Chiralix代理，ChiralixChiralix专业代理-上海金畔生物科技有限公司，具体产品信息欢迎电询：021-50837765
详细介绍
产品咨询
Chiralix是一家专业从事手性有机分子合成和供应的公司，我们致力于制药公司及生命科学研究领域的实验室研究用*手性分子的生产和研发。我们集先进的有机分子合成、过渡金属催化、生物催化技术于一身，具备灵活与高效的多种手性分子合成工艺，如基团的氨基酸，叠氮酸，氨基醇及多种肽段模块。除了提供大量的手性分子成品，我们还提供优质的研发服务，如复杂有机分子的合成等。
产品列表
| 货号 | 品名 | 化学名 | CAS号 | 分子量 | 分子式 | Synonyms | 纯度 | 包装 | 价格 | 品牌 |
| CX90418-1G | L-allysine ethylene acetal | (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid | 215054-80-1 | 189.21 | C8 H15 N O4 | H-Aea-OH | 99% | 1 G | 6200 | chiralix |
| CX90418-2G | L-allysine ethylene acetal | (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid | 215054-80-1 | 189.21 | C8 H15 N O4 | H-Aea-OH | 99% | 2 G | 10600 | chiralix |
| CX90418-5G | L-allysine ethylene acetal | (S)-2-amino-5-(1,3-dioxolan-2-yl)-pentanoic acid | 215054-80-1 | 189.21 | C8 H15 N O4 | H-Aea-OH | 99% | 5 G | 19900 | chiralix |
| CX60325-200MG | D-homopropargylglycine | (R)-2-aminohex-5-ynoic acid | 211054-02-3 | 127.14 | C6 H9 N O2 | H-D-Hpg-OH | >98% | 200 MG | 4800 | chiralix |
| CX60325-500MG | D-homopropargylglycine | (R)-2-aminohex-5-ynoic acid | 211054-02-3 | 127.14 | C6 H9 N O2 | H-D-Hpg-OH | >98% | 500 MG | 9800 | chiralix |
| CX60325-1G | D-homopropargylglycine | (R)-2-aminohex-5-ynoic acid | 211054-02-3 | 127.14 | C6 H9 N O2 | H-D-Hpg-OH | >98% | 1 G | 16000 | chiralix |
| CX80065-500MG | Fmoc-L-homopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | 942518-21-0 | 349.38 | C21 H19 N O4 | Fmoc-Hpg-OH | >97% | 500 MG | 11200 | chiralix |
| CX80065-1G | Fmoc-L-homopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | 942518-21-0 | 349.38 | C21 H19 N O4 | Fmoc-Hpg-OH | >97% | 1 G | 18400 | chiralix |
| CX90138-200MG | L-homopropargylglycine | (S)-2-aminohex-5-ynoic acid | 98891-36-2 | 127.14 | C6 H9 N O2 | H-Hpg-OH | >98% | 200 MG | 4800 | chiralix |
| CX90138-500MG | L-homopropargylglycine | (S)-2-aminohex-5-ynoic acid | 98891-36-2 | 127.14 | C6 H9 N O2 | H-Hpg-OH | >98% | 500 MG | 9800 | chiralix |
| CX90138-1G | L-homopropargylglycine | (S)-2-aminohex-5-ynoic acid | 98891-36-2 | 127.14 | C6 H9 N O2 | H-Hpg-OH | >98% | 1 G | 16000 | chiralix |
| CX56292-500MG | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | 108646-25-9 | 156.14 | C7 H8 O4 | >97% | 500 MG | 6000 | chiralix | |
| CX56292-1G | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylic acid | 108646-25-9 | 156.14 | C7 H8 O4 | >97% | 1 G | 9800 | chiralix | |
| CX24022-500MG | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | 38127-17-2 | 155.15 | C7 H9 N O3 | >98% | 500 MG | 6000 | chiralix | |
| CX24022-1G | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | (5S,6S)-6-amino-5-hydroxycyclohexa-1,3-dienecarboxylic acid | 38127-17-2 | 155.15 | C7 H9 N O3 | >98% | 1 G | 9800 | chiralix | |
| CX41399-1G | (S)-beta3-phenylalanine | (S)-3-amino-3-phenylpropanoic acid | 40856-44-8 | 165.19 | C9 H11 N O2 | 99% | 1 G | 2200 | chiralix | |
| CX41399-2G | (S)-beta3-phenylalanine | (S)-3-amino-3-phenylpropanoic acid | 40856-44-8 | 165.19 | C9 H11 N O2 | 99% | 2 G | 3800 | chiralix | |
| CX41399-5G | (S)-beta3-phenylalanine | (S)-3-amino-3-phenylpropanoic acid | 40856-44-8 | 165.19 | C9 H11 N O2 | 99% | 5 G | 7200 | chiralix | |
| CX64691-1G | D-tert-leucine | (R)-2-amino-3,3-dimethylbutyric acid | 26782-71-8 | 131.17 | C6 H13 N O2 | H-D-tert-Leu-OH | 99% | 1 G | 2200 | chiralix |
| CX64691-2G | D-tert-leucine | (R)-2-amino-3,3-dimethylbutyric acid | 26782-71-8 | 131.17 | C6 H13 N O2 | H-D-tert-Leu-OH | 99% | 2 G | 3800 | chiralix |
| CX64691-5G | D-tert-leucine | (R)-2-amino-3,3-dimethylbutyric acid | 26782-71-8 | 131.17 | C6 H13 N O2 | H-D-tert-Leu-OH | 99% | 5 G | 7200 | chiralix |
| CX97471-500MG | (S)-alpha-methyl-phenylglycine | (S)-2-amino-2-phenylpropanoic acid | 13398-26-0 | 165.19 | C9 H11 N O2 | (S)-H-Mpg-OH | >98% | 500 MG | 5200 | chiralix |
| CX97471-1G | (S)-alpha-methyl-phenylglycine | (S)-2-amino-2-phenylpropanoic acid | 13398-26-0 | 165.19 | C9 H11 N O2 | (S)-H-Mpg-OH | >98% | 1 G | 9000 | chiralix |
| CX97471-2G | (S)-alpha-methyl-phenylglycine | (S)-2-amino-2-phenylpropanoic acid | 13398-26-0 | 165.19 | C9 H11 N O2 | (S)-H-Mpg-OH | >98% | 2 G | 14800 | chiralix |
| CX58692-1G | (S)-allylglycinol hydrochloride | (S)-2-aminopent-4-en-1-ol hydrochloride | 926660-03-9 | 137.61 | C5 H12 Cl N O | >98% | 1 G | 7400 | chiralix | |
| CX58692-2G | (S)-allylglycinol hydrochloride | (S)-2-aminopent-4-en-1-ol hydrochloride | 926660-03-9 | 137.61 | C5 H12 Cl N O | >98% | 2 G | 12800 | chiralix | |
| CX40529-1G | (S)-propargylglycinol hydrochloride | (S)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 1 G | 8200 | chiralix | |
| CX40529-2G | (S)-propargylglycinol hydrochloride | (S)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 2 G | 14000 | chiralix | |
| CX80916-500MG | bis(N-Cbz)-2-deoxystreptamine | benzyl 4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 6216-32-6 | 430.45 | C22 H26 N2 O7 | bis-Z-2-DOS | >95% | 500 MG | 6200 | chiralix |
| CX80916-1G | bis(N-Cbz)-2-deoxystreptamine | benzyl 4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 6216-32-6 | 430.45 | C22 H26 N2 O7 | bis-Z-2-DOS | >95% | 1 G | 10800 | chiralix |
| CX93851-100MG | (2S,5R)-5-hydroxypipecolic acid hydrochloride | (2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride | 824943-40-0 | 181.62 | C6 H12 Cl N O3 | >98% | 100 MG | 3800 | chiralix | |
| CX93851-500MG | (2S,5R)-5-hydroxypipecolic acid hydrochloride | (2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride | 824943-40-0 | 181.62 | C6 H12 Cl N O3 | >98% | 500 MG | 12600 | chiralix | |
| CX93851-1G | (2S,5R)-5-hydroxypipecolic acid hydrochloride | (2S,5R)-5-hydroxypiperidine-2-carboxylic acid hydrochloride | 824943-40-0 | 181.62 | C6 H12 Cl N O3 | >98% | 1 G | 19600 | chiralix | |
| CX19922-1G | (S)-beta3-phenylalanine methyl ester hydrochloride | (S)-methyl 3-amino-3-phenylpropanoate hydrochloride | 144494-72-4 | 215.68 | C10 H14 Cl N O2 | >98% | 1 G | 3000 | chiralix | |
| CX19922-2G | (S)-beta3-phenylalanine methyl ester hydrochloride | (S)-methyl 3-amino-3-phenylpropanoate hydrochloride | 144494-72-4 | 215.68 | C10 H14 Cl N O2 | >98% | 2 G | 5200 | chiralix | |
| CX19922-5G | (S)-beta3-phenylalanine methyl ester hydrochloride | (S)-methyl 3-amino-3-phenylpropanoate hydrochloride | 144494-72-4 | 215.68 | C10 H14 Cl N O2 | >98% | 5 G | 9800 | chiralix | |
| CX62577-10MG | 6,8a-diepi-castanospermine | (1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol | 106798-21-0 | 189.21 | C8 H15 N O4 | >98% | 10 MG | 3600 | chiralix | |
| CX62577-50MG | 6,8a-diepi-castanospermine | (1S,6R,7R,8R,8aS)-octahydroindolizine-1,6,7,8-tetraol | 106798-21-0 | 189.21 | C8 H15 N O4 | >98% | 50 MG | 11800 | chiralix | |
| CX25404-1G | Fmoc-L-azidoornithine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoic acid | 1097192-04-5 | 380.40 | C20 H20 N4 O4 | Fmoc-Orn(N2)-OH | >98% | 1 G | 3400 | chiralix |
| CX25404-5G | Fmoc-L-azidoornithine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-azidopentanoic acid | 1097192-04-5 | 380.40 | C20 H20 N4 O4 | Fmoc-Orn(N2)-OH | >98% | 5 G | 12000 | chiralix |
| CX23880-5MG | rac-GR24 | (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one | 76974-79-3 | 298.29 | C17 H14 O5 | >98% | 5 MG | 5000 | chiralix | |
| CX23880-20MG | rac-GR24 | (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one | 76974-79-3 | 298.29 | C17 H14 O5 | >98% | 20 MG | 15000 | chiralix | |
| CX23880-100MG | rac-GR24 | (3aR*,8bS*,E)-3-(((R*)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-inde,2-b]furan-2-one | 76974-79-3 | 298.29 | C17 H14 O5 | >98% | 100 MG | 35000 | chiralix | |
| CX38605-1G | Fmoc-L-allysine ethylene acetal | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 411.45 | C23 H25 N O6 | Fmoc-Aea-OH | >97% | 1 G | 7200 | chiralix |
| CX38605-2G | Fmoc-L-allysine ethylene acetal | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 411.45 | C23 H25 N O6 | Fmoc-Aea-OH | >97% | 2 G | 12400 | chiralix |
| CX59650-1G | Fmoc-L-azidohomoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoic acid | 942518-20-9 | 366.37 | C19 H18 N4 O4 | Fmoc-Azh-OH | >98% | 1 G | 3400 | chiralix |
| CX59650-5G | Fmoc-L-azidohomoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-azidobutanoic acid | 942518-20-9 | 366.37 | C19 H18 N4 O4 | Fmoc-Azh-OH | >98% | 5 G | 12000 | chiralix |
| CX94894-200MG | L-bishomopropargylglycine | (S)-2-aminohept-6-ynoic acid | 835627-45-7 | 141.17 | C7 H11 N O2 | H-Bpg-OH | >98% | 200 MG | 4400 | chiralix |
| CX94894-500MG | L-bishomopropargylglycine | (S)-2-aminohept-6-ynoic acid | 835627-45-7 | 141.17 | C7 H11 N O2 | H-Bpg-OH | >98% | 500 MG | 9000 | chiralix |
| CX94894-1G | L-bishomopropargylglycine | (S)-2-aminohept-6-ynoic acid | 835627-45-7 | 141.17 | C7 H11 N O2 | H-Bpg-OH | >98% | 1 G | 14600 | chiralix |
| CX13745-1G | (R)-propargylglycinol hydrochloride | (R)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 1 G | 8200 | chiralix | |
| CX13745-2G | (R)-propargylglycinol hydrochloride | (R)-2-aminopent-4-yn-1-ol hydrochloride | Not available | 135.59 | C5 H10 Cl N O | >98% | 2 G | 14000 | chiralix | |
| CX78500-1G | (R)-allylglycinol hydrochloride | (R)-2-aminopent-4-en-1-ol hydrochloride | 926660-30-2 | 137.61 | C5 H12 Cl N O | >98% | 1 G | 7400 | chiralix | |
| CX78500-2G | (R)-allylglycinol hydrochloride | (R)-2-aminopent-4-en-1-ol hydrochloride | 926660-30-2 | 137.61 | C5 H12 Cl N O | >98% | 2 G | 12800 | chiralix | |
| CX69324-500MG | bis(N-Boc)-2-deoxystreptamine | tert-butyl (1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 189157-45-7 | 362.42 | C16 H30 N2 O7 | bis-Boc-2-DOS | >95% | 500 MG | 6200 | chiralix |
| CX69324-1G | bis(N-Boc)-2-deoxystreptamine | tert-butyl (1R,3S,4R,5r,6S)-4,5,6-trihydroxycyclohexane-1,3-diyldicarbamate | 189157-45-7 | 362.42 | C16 H30 N2 O7 | bis-Boc-2-DOS | >95% | 1 G | 10800 | chiralix |
| CX96388-1G | Boc-L-allysine ethylene acetal | (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 289.32 | C13 H23 N O6 | Boc-Aea-OH | >98% | 1 G | 6200 | chiralix |
| CX96388-2G | Boc-L-allysine ethylene acetal | (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 289.32 | C13 H23 N O6 | Boc-Aea-OH | >98% | 2 G | 10600 | chiralix |
| CX96388-5G | Boc-L-allysine ethylene acetal | (S)-2-(tert-butoxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | Not available | 289.32 | C13 H23 N O6 | Boc-Aea-OH | >98% | 5 G | 19900 | chiralix |
| CX42388-1G | Cbz-L-allysine ethylene acetal | (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | 852822-01-6 | 323.34 | C16 H21 N O6 | Z-Aea-OH | >98% | 1 G | 6200 | chiralix |
| CX42388-2G | Cbz-L-allysine ethylene acetal | (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | 852822-01-6 | 323.34 | C16 H21 N O6 | Z-Aea-OH | >98% | 2 G | 10600 | chiralix |
| CX42388-5G | Cbz-L-allysine ethylene acetal | (S)-2-(benzyloxycarbonylamino)-5-(1,3-dioxolan-2-yl)pentanoic acid | 852822-01-6 | 323.34 | C16 H21 N O6 | Z-Aea-OH | >98% | 5 G | 19900 | chiralix |
| CX44656-500MG | Boc-L-homopropargylglycine | (S)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | 208522-16-1 | 227.26 | C11 H17 N O4 | Boc-Hpg-OH | >98% | 500 MG | 9800 | chiralix |
| CX44656-1G | Boc-L-homopropargylglycine | (S)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | 208522-16-1 | 227.26 | C11 H17 N O4 | Boc-Hpg-OH | >98% | 1 G | 16000 | chiralix |
| CX69013-500MG | Cbz-L-homopropargylglycine | (S)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-Hpg-OH | >98% | 500 MG | 9800 | chiralix |
| CX69013-1G | Cbz-L-homopropargylglycine | (S)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-Hpg-OH | >98% | 1 G | 16000 | chiralix |
| CX54783-500MG | Boc-D-homopropargylglycine | (R)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | Not available | 227.26 | C11 H17 N O4 | Boc-D-Hpg-OH | >98% | 500 MG | 9800 | chiralix |
| CX54783-1G | Boc-D-homopropargylglycine | (R)-2-(tert-butoxycarbonylamino)hex-5-ynoic acid | Not available | 227.26 | C11 H17 N O4 | Boc-D-Hpg-OH | >98% | 1 G | 16000 | chiralix |
| CX14845-500MG | Cbz-D-homopropargylglycine | (R)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-D-Hpg-OH | >98% | 500 MG | 9800 | chiralix |
| CX14845-1G | Cbz-D-homopropargylglycine | (R)-2-(benzyloxycarbonylamino)hex-5-ynoic acid | Not available | 261.27 | C14 H15 N O4 | Z-D-Hpg-OH | >98% | 1 G | 16000 | chiralix |
| CX87818-500MG | Fmoc-D-homopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | Not available | 349.38 | C21 H19 N O4 | Fmoc-D-Hpg-OH | >97% | 500 MG | 11200 | chiralix |
| CX87818-1G | Fmoc-D-homopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hex-5-ynoic acid | Not available | 349.38 | C21 H19 N O4 | Fmoc-D-Hpg-OH | >97% | 1 G | 18400 | chiralix |
| CX57816-500MG | Fmoc-L-bishomopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-Bpg-OH | >97% | 500 MG | 10400 | chiralix |
| CX57816-1G | Fmoc-L-bishomopropargylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-Bpg-OH | >97% | 1 G | 16800 | chiralix |
| CX32424-200MG | D-bishomopropargylglycine | (R)-2-aminohept-6-ynoic acid | 211054-03-4 | 141.17 | C7 H11 N O2 | H-D-Bpg-OH | >98% | 200 MG | 4400 | chiralix |
| CX32424-500MG | D-bishomopropargylglycine | (R)-2-aminohept-6-ynoic acid | 211054-03-4 | 141.17 | C7 H11 N O2 | H-D-Bpg-OH | >98% | 500 MG | 9000 | chiralix |
| CX32424-1G | D-bishomopropargylglycine | (R)-2-aminohept-6-ynoic acid | 211054-03-4 | 141.17 | C7 H11 N O2 | H-D-Bpg-OH | >98% | 1 G | 14600 | chiralix |
| CX80846-500MG | Fmoc-D-bishomopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-D-Bpg-OH | >97% | 500 MG | 10400 | chiralix |
| CX80846-1G | Fmoc-D-bishomopropargylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hept-6-ynoic acid | Not available | 363.41 | C22 H21 N O4 | Fmoc-D-Bpg-OH | >97% | 1 G | 16800 | chiralix |
| CX52977-1G | (S)-Boc-beta3-phenylalanine | (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid | 103365-47-5 | 265.30 | C14 H19 N O4 | >98% | 1 G | 2200 | chiralix | |
| CX52977-2G | (S)-Boc-beta3-phenylalanine | (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid | 103365-47-5 | 265.30 | C14 H19 N O4 | >98% | 2 G | 3800 | chiralix | |
| CX52977-5G | (S)-Boc-beta3-phenylalanine | (S)-3-(tert-butoxycarbonylamino)-3-phenylpropanoic acid | 103365-47-5 | 265.30 | C14 H19 N O4 | >98% | 5 G | 7200 | chiralix | |
| CX79659-1G | (S)-Cbz-beta3-phenylalanine | (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid | 14441-08-8 | 299.32 | C17 H17 N O4 | >98% | 1 G | 2200 | chiralix | |
| CX79659-2G | (S)-Cbz-beta3-phenylalanine | (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid | 14441-08-8 | 299.32 | C17 H17 N O4 | >98% | 2 G | 3800 | chiralix | |
| CX79659-5G | (S)-Cbz-beta3-phenylalanine | (S)-3-(benzyloxycarbonylamino)-3-phenylpropanoic acid | 14441-08-8 | 299.32 | C17 H17 N O4 | >98% | 5 G | 7200 | chiralix | |
| CX56872-1G | (S)-Fmoc-beta3-phenylalanine | (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid | 209252-15-3 | 387.43 | C24 H21 N O4 | >98% | 1 G | 2600 | chiralix | |
| CX56872-2G | (S)-Fmoc-beta3-phenylalanine | (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid | 209252-15-3 | 387.43 | C24 H21 N O4 | >98% | 2 G | 4400 | chiralix | |
| CX56872-5G | (S)-Fmoc-beta3-phenylalanine | (S)-3-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-phenylpropanoic acid | 209252-15-3 | 387.43 | C24 H21 N O4 | >98% | 5 G | 8600 | chiralix | |
| CX44048-1G | Boc-D-tert-leucine | (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid | 124655-17-0 | 231.29 | C11 H21 N O4 | Boc-D-tert-Leu-OH | >98% | 1 G | 2200 | chiralix |
| CX44048-2G | Boc-D-tert-leucine | (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid | 124655-17-0 | 231.29 | C11 H21 N O4 | Boc-D-tert-Leu-OH | >98% | 2 G | 3800 | chiralix |
| CX44048-5G | Boc-D-tert-leucine | (R)-2-(tert-butoxycarbonylamino)-3,3-dimethylbutanoic acid | 124655-17-0 | 231.29 | C11 H21 N O4 | Boc-D-tert-Leu-OH | >98% | 5 G | 7200 | chiralix |
| CX22855-1G | Fmoc-D-tert-leucine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid | 198543-64-5 | 353.41 | C21 H23 N O4 | Fmoc-D-tert-Leu-OH | >97% | 1 G | 2600 | chiralix |
| CX22855-2G | Fmoc-D-tert-leucine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid | 198543-64-5 | 353.41 | C21 H23 N O4 | Fmoc-D-tert-Leu-OH | >97% | 2 G | 4400 | chiralix |
| CX22855-5G | Fmoc-D-tert-leucine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3,3-dimethylbutanoic acid | 198543-64-5 | 353.41 | C21 H23 N O4 | Fmoc-D-tert-Leu-OH | >97% | 5 G | 8600 | chiralix |
| CX28901-1G | (S)-Boc-alpha-methyl-phenylglycine | (S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoic acid | 802541-88-4 | 265.30 | C14 H19 N O4 | (S)-Boc-Mpg-OH | >98% | 1 G | 9000 | chiralix |
| CX28901-2G | (S)-Boc-alpha-methyl-phenylglycine | (S)-2-(tert-butoxycarbonylamino)-2-phenylpropanoic acid | 802541-88-4 | 265.30 | C14 H19 N O4 | (S)-Boc-Mpg-OH | >98% | 2 G | 14800 | chiralix |
| CX28344-1G | (S)-Fmoc-alpha-methyl-phenylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881921-11-5 | 387.43 | C24 H21 N O4 | (S)-Fmoc-Mpg-OH | >98% | 1 G | 10400 | chiralix |
| CX28344-2G | (S)-Fmoc-alpha-methyl-phenylglycine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881921-11-5 | 387.43 | C24 H21 N O4 | (S)-Fmoc-Mpg-OH | >98% | 2 G | 17200 | chiralix |
| CX93005-1G | Fmoc-L-azidoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoic acid | 684270-46-0 | 352.34 | C18 H16 N4 O4 | Fmoc-Aza-OH | >98% | 1 G | 3400 | chiralix |
| CX93005-5G | Fmoc-L-azidoalanine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-azidopropanoic acid | 684270-46-0 | 352.34 | C18 H16 N4 O4 | Fmoc-Aza-OH | >98% | 5 G | 12000 | chiralix |
| CX90286-200MG | bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine | 4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate | 90852-19-0 | 340.29 | C12 H16 N6 O6 | 2-DOS diazide triacetate | >98% | 200 MG | 4200 | chiralix |
| CX90286-500MG | bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine | 4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate | 90852-19-0 | 340.29 | C12 H16 N6 O6 | 2-DOS diazide triacetate | >98% | 500 MG | 8800 | chiralix |
| CX90286-1G | bis(N-diazo)-tris(O-acetyl)-2-deoxystreptamine | 4t,6t-diazidocyclohexane-1r,2t,3c-triyl triacetate | 90852-19-0 | 340.29 | C12 H16 N6 O6 | 2-DOS diazide triacetate | >98% | 1 G | 15200 | chiralix |
| CX44848-200MG | (R)-4-oxopipecolic acid ethylene acetal | (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 200 MG | 5200 | chiralix | |
| CX44848-500MG | (R)-4-oxopipecolic acid ethylene acetal | (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 500 MG | 11000 | chiralix | |
| CX44848-1G | (R)-4-oxopipecolic acid ethylene acetal | (R)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 1 G | 19200 | chiralix | |
| CX45124-500MG | (R)-alpha-methyl-phenylglycine | (R)-2-amino-2-phenylpropanoic acid | 29738-09-8 | 165.19 | C9 H11 N O2 | (R)-H-Mpg-OH | >98% | 500 MG | 6200 | chiralix |
| CX45124-1G | (R)-alpha-methyl-phenylglycine | (R)-2-amino-2-phenylpropanoic acid | 29738-09-8 | 165.19 | C9 H11 N O2 | (R)-H-Mpg-OH | >98% | 1 G | 10400 | chiralix |
| CX45124-2G | (R)-alpha-methyl-phenylglycine | (R)-2-amino-2-phenylpropanoic acid | 29738-09-8 | 165.19 | C9 H11 N O2 | (R)-H-Mpg-OH | >98% | 2 G | 17200 | chiralix |
| CX43844-1G | L-azidoleucine CHA salt | cyclohexanaminium (S)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Leu-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX43844-5G | L-azidoleucine CHA salt | cyclohexanaminium (S)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Leu-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX66793-1G | L-azidovaline CHA salt | cyclohexanaminium (S)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-Val-OH · CHA | >98% | 1 G | 2600 | chiralix |
| CX66793-5G | L-azidovaline CHA salt | cyclohexanaminium (S)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-Val-OH · CHA | >98% | 5 G | 9800 | chiralix |
| CX90285-1G | L-azidotryptophan CHA salt | cyclohexanaminium (S)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-Trp-OH · CHA | >98% | 1 G | 2400 | chiralix |
| CX90285-5G | L-azidotryptophan CHA salt | cyclohexanaminium (S)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-Trp-OH · CHA | >98% | 5 G | 9000 | chiralix |
| CX32182-1G | L-azidoalanine CHA salt | cyclohexanaminium (S)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-Ala-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX32182-5G | L-azidoalanine CHA salt | cyclohexanaminium (S)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-Ala-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX33085-1G | L-azidophenylalanine CHA salt | cyclohexanaminium (S)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | N3-Phe-OH · CHA | >98% | 1 G | 2400 | chiralix |
| CX33085-5G | L-azidophenylalanine CHA salt | cyclohexanaminium (S)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | N3-Phe-OH · CHA | >98% | 5 G | 9000 | chiralix |
| CX37236-1G | L-azidoisoleucine CHA salt | cyclohexanaminium (2S,3S)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Ile-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX37236-5G | L-azidoisoleucine CHA salt | cyclohexanaminium (2S,3S)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-Ile-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX81236-1G | L-azidotyrosine CHA salt | cyclohexanaminium (S)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-Tyr-OH · CHA | >97% | 1 G | 2800 | chiralix |
| CX81236-5G | L-azidotyrosine CHA salt | cyclohexanaminium (S)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-Tyr-OH · CHA | >97% | 5 G | 10600 | chiralix |
| CX84940-1G | L-azidomethionine CHA salt | cyclohexanaminium (S)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-Met-OH · CHA | >98% | 1 G | 2600 | chiralix |
| CX84940-5G | L-azidomethionine CHA salt | cyclohexanaminium (S)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-Met-OH · CHA | >98% | 5 G | 9800 | chiralix |
| CX81456-200MG | (S)-5-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 200 MG | 5200 | chiralix | |
| CX81456-500MG | (S)-5-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 500 MG | 11000 | chiralix | |
| CX81456-1G | (S)-5-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-7-azaspiro[4.5]decane-8-carboxylic acid | Not available | 187.19 | C8 H13 N O4 | >98% | 1 G | 19200 | chiralix | |
| CX80632-1G | L-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-Thr(OtBu)-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX80632-5G | L-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-Thr(OtBu)-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX59871-1G | L-azidoserine CHA salt | cyclohexanaminium (S)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-Ser-OH · CHA | >98% | 1 G | 2600 | chiralix |
| CX59871-5G | L-azidoserine CHA salt | cyclohexanaminium (S)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-Ser-OH · CHA | >98% | 5 G | 9800 | chiralix |
| CX20625-1G | L-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-Asp(OtBu)-OH · CHA | >98% | 1 G | 2600 | chiralix |
| CX20625-5G | L-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-Asp(OtBu)-OH · CHA | >98% | 5 G | 9800 | chiralix |
| CX24163-1G | L-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-Glu(OtBu)-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX24163-5G | L-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (S)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-Glu(OtBu)-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX68680-1G | L-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-Tyr(OtBu)-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX68680-5G | L-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-Tyr(OtBu)-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX55921-1G | L-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-Ser(OtBu)-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX55921-5G | L-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (S)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-Ser(OtBu)-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX54776-200MG | (S)-4-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | 356073-54-6 | 187.19 | C8 H13 N O4 | >98% | 200 MG | 5200 | chiralix | |
| CX54776-500MG | (S)-4-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | 356073-54-6 | 187.19 | C8 H13 N O4 | >98% | 500 MG | 11000 | chiralix | |
| CX54776-1G | (S)-4-oxopipecolic acid ethylene acetal | (S)-1,4-dioxa-8-azaspiro[4.5]decane-7-carboxylic acid | 356073-54-6 | 187.19 | C8 H13 N O4 | >98% | 1 G | 19200 | chiralix | |
| CX46058-1G | D-azidovaline CHA salt | cyclohexanaminium (R)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-D-Val-OH · CHA | >98% | 1 G | 3000 | chiralix |
| CX46058-5G | D-azidovaline CHA salt | cyclohexanaminium (R)-2-azido-3-methylbutanoate | Not available | 242.32 | C11 H22 N4 O2 | N3-D-Val-OH · CHA | >98% | 5 G | 11200 | chiralix |
| CX44158-1G | D-azidoalanine CHA salt | cyclohexanaminium (R)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-D-Ala-OH · CHA | >98% | 1 G | 3400 | chiralix |
| CX44158-5G | D-azidoalanine CHA salt | cyclohexanaminium (R)-2-azidopropanoate | Not available | 214.26 | C9 H18 N4 O2 | N3-D-Ala-OH · CHA | >98% | 5 G | 12800 | chiralix |
| CX27954-1G | D-azidophenylalanine CHA salt | cyclohexanaminium (R)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | D-N3-Phe-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX27954-5G | D-azidophenylalanine CHA salt | cyclohexanaminium (R)-2-azido-3-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | D-N3-Phe-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX56656-1G | D-azidomethionine CHA salt | cyclohexanaminium (R)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-D-Met-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX56656-5G | D-azidomethionine CHA salt | cyclohexanaminium (R)-2-azido-4-(methylthio)butanoate | Not available | 274.38 | C11 H22 N4 O2 S | N3-D-Met-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX16129-500MG | Cbz-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-Bpg-OH · CHA | >98% | 500 MG | 9000 | chiralix |
| CX16129-1G | Cbz-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-Bpg-OH · CHA | >98% | 1 G | 14600 | chiralix |
| CX65817-1G | (S)-Cbz-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate | Not available | 398.50 | C23 H30 N2 O4 | (S)-Cbz-Mpg-OH · CHA | >98% | 1 G | 9000 | chiralix |
| CX65817-2G | (S)-Cbz-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-(benzyloxycarbonylamino)-2-phenylpropanoate | Not available | 398.50 | C23 H30 N2 O4 | (S)-Cbz-Mpg-OH · CHA | >98% | 2 G | 14800 | chiralix |
| CX19691-500MG | Boc-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-D-Bpg-OH · CHA | >98% | 500 MG | 9000 | chiralix |
| CX19691-1G | Boc-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-D-Bpg-OH · CHA | >98% | 1 G | 14600 | chiralix |
| CX59796-500MG | Boc-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-Bpg-OH · CHA | >98% | 500 MG | 9000 | chiralix |
| CX59796-1G | Boc-L-bishomopropargylglycine CHA salt | cyclohexanaminium (S)-2-(tert-butoxycarbonylamino)hept-6-ynoate | Not available | 340.46 | C18 H32 N2 O4 | Boc-Bpg-OH · CHA | >98% | 1 G | 14600 | chiralix |
| CX79723-1G | (R)-Fmoc-alpha-methyl-phenylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881920-86-1 | 387.43 | C24 H21 N O4 | (R)-Fmoc-Mpg-OH | >98% | 1 G | 12000 | chiralix |
| CX79723-2G | (R)-Fmoc-alpha-methyl-phenylglycine | (R)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-2-phenylpropanoic acid | 881920-86-1 | 387.43 | C24 H21 N O4 | (R)-Fmoc-Mpg-OH | >98% | 2 G | 19800 | chiralix |
| CX32015-1G | Cbz-D-tert-leucine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate | Not available | 364.48 | C20 H32 N2 O4 | Z-D-tert-Leu-OH · CHA | >98% | 1 G | 2200 | chiralix |
| CX32015-2G | Cbz-D-tert-leucine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate | Not available | 364.48 | C20 H32 N2 O4 | Z-D-tert-Leu-OH · CHA | >98% | 2 G | 3800 | chiralix |
| CX32015-5G | Cbz-D-tert-leucine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)-3,3-dimethylbutanoate | Not available | 364.48 | C20 H32 N2 O4 | Z-D-tert-Leu-OH · CHA | >98% | 5 G | 7200 | chiralix |
| CX81118-1G | Fmoc-L-azidolysine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoic acid | 159610-89-6 | 394.42 | C21 H22 N4 O4 | Fmoc-Lys(N2)-OH | >98% | 1 G | 3400 | chiralix |
| CX81118-5G | Fmoc-L-azidolysine | (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-azidohexanoic acid | 159610-89-6 | 394.42 | C21 H22 N4 O4 | Fmoc-Lys(N2)-OH | >98% | 5 G | 12000 | chiralix |
| CX19587-500MG | Cbz-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-D-Bpg-OH · CHA | >98% | 500 MG | 9000 | chiralix |
| CX19587-1G | Cbz-D-bishomopropargylglycine CHA salt | cyclohexanaminium (R)-2-(benzyloxycarbonylamino)hept-6-ynoate | Not available | 374.47 | C21 H30 N2 O4 | Z-D-Bpg-OH · CHA | >98% | 1 G | 14600 | chiralix |
| CX28021-500MG | H-Arg(Boc)2-pNA | (S,E)-tert-butyl (4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate | Not available | 494.54 | C22 H34 N6 O7 | >97% | 500 MG | 6000 | chiralix | |
| CX28021-1G | H-Arg(Boc)2-pNA | (S,E)-tert-butyl (4-amino-5-(4-nitrophenylamino)-5-oxopentylamino)(tert-butoxycarbonylamino)methylenecarbamate | Not available | 494.54 | C22 H34 N6 O7 | >97% | 1 G | 11000 | chiralix | |
| CX72798-1G | D-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-D-Asp(OtBu)-OH · CHA | >98% | 1 G | 6200 | chiralix |
| CX72798-5G | D-azidoaspartic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-4-tert-butoxy-4-oxobutanoate | Not available | 314.38 | C14 H26 N4 O4 | N3-D-Asp(OtBu)-OH · CHA | >98% | 5 G | 23400 | chiralix |
| CX93516-1G | D-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-D-Glu(OtBu)-OH · CHA | >98% | 1 G | 5200 | chiralix |
| CX93516-5G | D-azidoglutamic acid mono-tert-butyl ester CHA salt | cyclohexanaminium (R)-2-azido-5-tert-butoxy-5-oxopentanoate | Not available | 328.41 | C15 H28 N4 O4 | N3-D-Glu(OtBu)-OH · CHA | >98% | 5 G | 19600 | chiralix |
| CX76762-1G | D-azidoleucine CHA salt | cyclohexanaminium (R)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Leu-OH · CHA | >98% | 1 G | 3000 | chiralix |
| CX76762-5G | D-azidoleucine CHA salt | cyclohexanaminium (R)-2-azido-4-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Leu-OH · CHA | >98% | 5 G | 11200 | chiralix |
| CX53333-1G | D-azidoisoleucine CHA salt | cyclohexanaminium (2R,3R)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Ile-OH · CHA | >98% | 1 G | 9200 | chiralix |
| CX53333-2G | D-azidoisoleucine CHA salt | cyclohexanaminium (2R,3R)-2-azido-3-methylpentanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-Ile-OH · CHA | >98% | 2 G | 16400 | chiralix |
| CX83245-1G | D-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-D-Tyr(OtBu)-OH · CHA | >98% | 1 G | 5400 | chiralix |
| CX83245-5G | D-azidotyrosine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-(4-tert-butoxyphenyl)propanoate | Not available | 362.47 | C19 H30 N4 O3 | N3-D-Tyr(OtBu)-OH · CHA | >98% | 5 G | 20400 | chiralix |
| CX13425-1G | D-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-D-Ser(OtBu)-OH · CHA | >98% | 1 G | 7200 | chiralix |
| CX13425-5G | D-azidoserine tert-butyl ether CHA salt | cyclohexanaminium (R)-2-azido-3-tert-butoxypropanoate | Not available | 286.37 | C13 H26 N4 O3 | N3-D-Ser(OtBu)-OH · CHA | >98% | 5 G | 27200 | chiralix |
| CX29937-1G | D-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-D-Thr(OtBu)-OH · CHA | >98% | 1 G | 6400 | chiralix |
| CX29937-5G | D-azidothreonine tert-butyl ether CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-tert-butoxybutanoate | Not available | 300.40 | C14 H28 N4 O3 | N3-D-Thr(OtBu)-OH · CHA | >98% | 5 G | 24200 | chiralix |
| CX85233-1G | L-azidothreonine CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-Thr-OH · CHA | >98% | 1 G | 2600 | chiralix |
| CX85233-5G | L-azidothreonine CHA salt | cyclohexanaminium (2S,3R)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-Thr-OH · CHA | >98% | 5 G | 9800 | chiralix |
| CX37313-1G | D-azidothreonine CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-D-Thr-OH · CHA | >98% | 1 G | 3000 | chiralix |
| CX37313-5G | D-azidothreonine CHA salt | cyclohexanaminium (2R,3S)-2-azido-3-hydroxybutanoate | Not available | 244.29 | C10 H20 N4 O3 | N3-D-Thr-OH · CHA | >98% | 5 G | 11200 | chiralix |
| CX95405-1G | D-azidoserine CHA salt | cyclohexanaminium (R)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-D-Ser-OH · CHA | >98% | 1 G | 3200 | chiralix |
| CX95405-5G | D-azidoserine CHA salt | cyclohexanaminium (R)-2-azido-3-hydroxypropanoate | Not available | 230.26 | C9 H18 N4 O3 | N3-D-Ser-OH · CHA | >98% | 5 G | 12000 | chiralix |
| CX57717-1G | L-azidoglutamine DCHA salt | dicyclohexylammonium (S)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-Gln-OH · DCHA | >98% | 1 G | 2600 | chiralix |
| CX57717-5G | L-azidoglutamine DCHA salt | dicyclohexylammonium (S)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-Gln-OH · DCHA | >98% | 5 G | 9800 | chiralix |
| CX79807-1G | D-azidoglutamine DCHA salt | dicyclohexylammonium (R)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-D-Gln-OH · DCHA | >98% | 1 G | 3200 | chiralix |
| CX79807-5G | D-azidoglutamine DCHA salt | dicyclohexylammonium (R)-5-amino-2-azido-5-oxopentanoate | Not available | 353.46 | C17 H31 N5 O3 | N3-D-Gln-OH · DCHA | >98% | 5 G | 12000 | chiralix |
| CX94556-1G | L-azidoasparagine DCHA salt | dicyclohexylammonium (S)-4-amino-2-azido-4-oxobutanoate | 79410-49-4 | 339.43 | C16 H29 N5 O3 | N3-Asn-OH · DCHA | >98% | 1 G | 3200 | chiralix |
| CX94556-5G | L-azidoasparagine DCHA salt | dicyclohexylammonium (S)-4-amino-2-azido-4-oxobutanoate | 79410-49-4 | 339.43 | C16 H29 N5 O3 | N3-Asn-OH · DCHA | >98% | 5 G | 12000 | chiralix |
| CX83100-1G | D-azidoasparagine DCHA salt | dicyclohexylammonium (R)-4-amino-2-azido-4-oxobutanoate | Not available | 339.43 | C16 H29 N5 O3 | N3-D-Asn-OH · DCHA | >98% | 1 G | 4000 | chiralix |
| CX83100-5G | D-azidoasparagine DCHA salt | dicyclohexylammonium (R)-4-amino-2-azido-4-oxobutanoate | Not available | 339.43 | C16 H29 N5 O3 | N3-D-Asn-OH · DCHA | >98% | 5 G | 15000 | chiralix |
| CX48141-1G | D-azidotryptophan CHA salt | cyclohexanaminium (R)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-D-Trp-OH · CHA | >98% | 1 G | 2600 | chiralix |
| CX48141-5G | D-azidotryptophan CHA salt | cyclohexanaminium (R)-2-azido-3-(1H-indol-2-yl)propanoate | Not available | 329.40 | C17 H23 N5 O2 | N3-D-Trp-OH · CHA | >98% | 5 G | 9800 | chiralix |
| CX93426-1G | N-im-trityl-L-azidohistidine CHA salt | cyclohexanaminium (S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate | Not available | 522.64 | C31 H34 N6 O2 | N3-His(Trt)-OH · CHA | >98% | 1 G | 4000 | chiralix |
| CX93426-5G | N-im-trityl-L-azidohistidine CHA salt | cyclohexanaminium (S)-2-azido-3-(1-trityl-1H-imidazol-4-yl)propanoate | Not available | 522.64 | C31 H34 N6 O2 | N3-His(Trt)-OH · CHA | >98% | 5 G | 15000 | chiralix |
| CX24279-1G | D-azidotyrosine CHA salt | cyclohexanaminium (R)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-D-Tyr-OH · CHA | >98% | 1 G | 3600 | chiralix |
| CX24279-5G | D-azidotyrosine CHA salt | cyclohexanaminium (R)-2-azido-3-(4-hydroxyphenyl)propanoate | Not available | 306.36 | C15 H22 N4 O3 | N3-D-Tyr-OH · CHA | >98% | 5 G | 13600 | chiralix |
| CX78063-1G | L-azido-tert-leucine CHA salt | cyclohexanaminium (S)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-tert-Leu-OH · CHA | >98% | 1 G | 2800 | chiralix |
| CX78063-5G | L-azido-tert-leucine CHA salt | cyclohexanaminium (S)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-tert-Leu-OH · CHA | >98% | 5 G | 10600 | chiralix |
| CX30547-1G | D-azido-tert-leucine CHA salt | cyclohexanaminium (R)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-tert-Leu-OH · CHA | >98% | 1 G | 6600 | chiralix |
| CX30547-5G | D-azido-tert-leucine CHA salt | cyclohexanaminium (R)-2-azido-3,3-dimethylbutanoate | Not available | 256.34 | C12 H24 N4 O2 | N3-D-tert-Leu-OH · CHA | >98% | 5 G | 25000 | chiralix |
| CX78942-1G | L-azidoallylglycine CHA salt | cyclohexanaminium (S)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-Alg-OH · CHA | >98% | 1 G | 5600 | chiralix |
| CX78942-5G | L-azidoallylglycine CHA salt | cyclohexanaminium (S)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-Alg-OH · CHA | >98% | 5 G | 21200 | chiralix |
| CX61332-1G | D-azidoallylglycine CHA salt | cyclohexanaminium (R)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-D-Alg-OH · CHA | >98% | 1 G | 9000 | chiralix |
| CX61332-2G | D-azidoallylglycine CHA salt | cyclohexanaminium (R)-2-azidopent-4-enoate | Not available | 240.30 | C11 H20 N4 O2 | N3-D-Alg-OH · CHA | >98% | 2 G | 16000 | chiralix |
| CX56925-1G | Ng-Pmc-L-azidoarginine | (S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoic acid | Not available | 466.55 | C20 H30 N6 O5 S | Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine | >95% | 1 G | 4000 | chiralix |
| CX56925-5G | Ng-Pmc-L-azidoarginine | (S)-2-azido-5-(3-(2,2,5,7,8-pentamethylchroman-6-ylsulfonyl)guanidino)pentanoic acid | Not available | 466.55 | C20 H30 N6 O5 S | Ng-2,2,5,7,8-pentamethylchroman-6-sulfonyl-L-azidoarginine | >95% | 5 G | 15000 | chiralix |
| CX22361-1G | (S)-azido-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (S)-N3-Mpg-OH · CHA | >98% | 1 G | 9000 | chiralix |
| CX22361-2G | (S)-azido-alpha-methyl-phenylglycine CHA salt | cyclohexanaminium (S)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (S)-N3-Mpg-OH · CHA | >98% | 2 G | 14800 | chiralix |
| CX52265-1G | (R)-azido-alpha-methylphenylglycine CHA salt | cyclohexanaminium (R)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (R)-N3-Mpg-OH · CHA | >98% | 1 G | 10400 | chiralix |
| CX52265-2G | (R)-azido-alpha-methylphenylglycine CHA salt | cyclohexanaminium (R)-2-azido-2-phenylpropanoate | Not available | 290.36 | C15 H22 N4 O2 | (R)-N3-Mpg-OH · CHA | >98% | 2 G | 17200 | chiralix |
| CX71813-1G | S-Trityl-L-azidocysteine CHA salt | cyclohexanaminium (R)-2-azido-3-(tritylthio)propanoate | Not available | 488.64 | C28 H32 N4 O2 S | N3-Cys(Trt)-OH · CHA | >98% | 1 G | 3000 | chiralix |
| CX71813-5G | S-Trityl-L-azidocysteine CHA salt | cyclohexanaminium (R)-2-azido-3-(tritylthio)propanoate | Not available | 488.64 | C28 H32 N4 O2 S | N3-Cys(Trt)-OH · CHA | >98% | 5 G | 11200 | chiralix |
| CX40608-5G | 6-azidohexanoic acid | 6-azidohexanoic acid | 79598-53-1 | 157.17 | C6 H11 N3 O2 | >98% | 5 G | 6000 | chiralix | |
| CX40608-10G | 6-azidohexanoic acid | 6-azidohexanoic acid | 79598-53-1 | 157.17 | C6 H11 N3 O2 | >98% | 10 G | 11000 | chiralix | |
| CX23053-500MG | (S)-bishomopropargylglycinol hydrochloride | (S)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 500 MG | 10400 | chiralix | |
| CX23053-1G | (S)-bishomopropargylglycinol hydrochloride | (S)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 1 G | 17200 | chiralix | |
| CX63523-500MG | (R)-bishomopropargylglycinol hydrochloride | (R)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 500 MG | 10400 | chiralix | |
| CX63523-1G | (R)-bishomopropargylglycinol hydrochloride | (R)-2-aminohept-6-yn-1-ol hydrochloride | Not available | 163.65 | C7 H14 Cl N O | >98% | 1 G | 17200 | chiralix | |
| CX69091-500MG | (R)-homopropargylglycinol hydrochloride | (R)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 500 MG | 11000 | chiralix | |
| CX69091-1G | (R)-homopropargylglycinol hydrochloride | (R)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 1 G | 17800 | chiralix | |
| CX76358-500MG | (S)-homopropargylglycinol hydrochloride | (S)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 500 MG | 11000 | chiralix | |
| CX76358-1G | (S)-homopropargylglycinol hydrochloride | (S)-2-aminohex-5-yn-1-ol hydrochloride | Not available | 149.62 | C6 H12 Cl N O | >98% | 1 G | 17800 | chiralix | |
| CX55029-2MG | cereulide | cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 | Not available | 1153.40 | C57 H96 N6 O18 | >95% | 2 MG | 12000 | chiralix | |
| CX55029-5MG | cereulide | cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 | Not available | 1153.40 | C57 H96 N6 O18 | >95% | 5 MG | 24000 | chiralix | |
| CX45120-1G | H-Orn(Boc)-pNA | (S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate | Not available | 352.39 | C16 H24 N4 O5 | >98% | 1 G | 4000 | chiralix | |
| CX45120-2G | H-Orn(Boc)-pNA | (S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate | Not available | 352.39 | C16 H24 N4 O5 | >98% | 2 G | 9000 | chiralix | |
| CX45120-5G | H-Orn(Boc)-pNA | (S)-tert-butyl (4-amino-5-((4-nitrophenyl)amino)-5-oxopentyl)carbamate | Not available | 352.39 | C16 H24 N4 O5 | >98% | 5 G | 15000 | chiralix | |
| CX57163-2MG | 13C6-cereulide | cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3 | Not available | 1159.36 | C51 13 C6 H96 N6 O18 | >95% | 2 MG | 24000 | chiralix | |
| CX64158-1G | Fmoc-Orn-pNA · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 510.97 | C26 H27 Cl N4 O5 | Fmoc-Orn-pNA HCl salt | >98% | 1 G | 4000 | chiralix |
| CX64158-2G | Fmoc-Orn-pNA · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 510.97 | C26 H27 Cl N4 O5 | Fmoc-Orn-pNA HCl salt | >98% | 2 G | 7200 | chiralix |
| CX64158-5G | Fmoc-Orn-pNA · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-nitrophenyl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 510.97 | C26 H27 Cl N4 O5 | Fmoc-Orn-pNA HCl salt | >98% | 5 G | 15000 | chiralix |
| CX80044-250MG | Bis(H-Orn(Boc))-rhodamine 110 | Bis(H-Orn(Boc))-rhodamine | Not available | 758.86 | C40 H50 N6 O9 | >95% | 250 MG | 7600 | chiralix | |
| CX80044-500MG | Bis(H-Orn(Boc))-rhodamine 110 | Bis(H-Orn(Boc))-rhodamine | Not available | 758.86 | C40 H50 N6 O9 | >95% | 500 MG | 14000 | chiralix | |
| CX80044-1G | Bis(H-Orn(Boc))-rhodamine 110 | Bis(H-Orn(Boc))-rhodamine | Not available | 758.86 | C40 H50 N6 O9 | >95% | 1 G | 25000 | chiralix | |
| CX67830-250MG | Bis(H-Arg(Boc)2)-rhodamine 110 | Bis(H-Arg(Boc)2)-rhodamine | Not available | 1043.17 | C52 H70 N10 O13 | >95% | 250 MG | 7800 | chiralix | |
| CX67830-500MG | Bis(H-Arg(Boc)2)-rhodamine 110 | Bis(H-Arg(Boc)2)-rhodamine | Not available | 1043.17 | C52 H70 N10 O13 | >95% | 500 MG | 14400 | chiralix | |
| CX67830-1G | Bis(H-Arg(Boc)2)-rhodamine 110 | Bis(H-Arg(Boc)2)-rhodamine | Not available | 1043.17 | C52 H70 N10 O13 | >95% | 1 G | 26000 | chiralix | |
| CX18326-1G | Fmoc-Orn-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 548.03 | C30 H30 Cl N3 O5 | >98% | 1 G | 5000 | chiralix | |
| CX18326-2G | Fmoc-Orn-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 548.03 | C30 H30 Cl N3 O5 | >98% | 2 G | 9000 | chiralix | |
| CX18326-5G | Fmoc-Orn-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (5-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)carbamate hydrochloride | Not available | 548.03 | C30 H30 Cl N3 O5 | >98% | 5 G | 19000 | chiralix | |
| CX59077-1G | H-Orn(Boc)-AMC | (S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate | Not available | 389.45 | C20 H27 N3 O5 | >98% | 1 G | 6000 | chiralix | |
| CX59077-2G | H-Orn(Boc)-AMC | (S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate | Not available | 389.45 | C20 H27 N3 O5 | >98% | 2 G | 10800 | chiralix | |
| CX59077-5G | H-Orn(Boc)-AMC | (S)-tert-butyl (4-amino-5-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-5-oxopentyl)carbamate | Not available | 389.45 | C20 H27 N3 O5 | >98% | 5 G | 22000 | chiralix | |
| CX48623-1G | H-Lys(Boc)-AMC | (S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate | 222037-62-9 | 403.47 | C21 H29 N3 O5 | >98% | 1 G | 5000 | chiralix | |
| CX48623-2G | H-Lys(Boc)-AMC | (S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate | 222037-62-9 | 403.47 | C21 H29 N3 O5 | >98% | 2 G | 9000 | chiralix | |
| CX48623-5G | H-Lys(Boc)-AMC | (S)-tert-butyl (5-amino-6-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-6-oxohexyl)carbamate | 222037-62-9 | 403.47 | C21 H29 N3 O5 | >98% | 5 G | 19000 | chiralix | |
| CX55361-500MG | H-Arg(Boc)2-AMC | H-Arg(Boc)2-AMC | Not available | 531.60 | C26 H37 N5 O7 | >97% | 500 MG | 6000 | chiralix | |
| CX55361-1G | H-Arg(Boc)2-AMC | H-Arg(Boc)2-AMC | Not available | 531.60 | C26 H37 N5 O7 | >97% | 1 G | 10800 | chiralix | |
| CX84944-1G | Fmoc-Lys-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride | Not available | 562.06 | C31 H32 Cl N3 O5 | >98% | 1 G | 4000 | chiralix | |
| CX84944-2G | Fmoc-Lys-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride | Not available | 562.06 | C31 H32 Cl N3 O5 | >98% | 2 G | 7200 | chiralix | |
| CX84944-5G | Fmoc-Lys-AMC · HCl | (S)-(9H-fluoren-9-yl)methyl (6-ami-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxohexan-2-yl)carbamate hydrochloride | Not available | 562.06 | C31 H32 Cl N3 O5 | >98% | 5 G | 15000 | chiralix | |
| CX69359-5G | 4-azidobutyric acid | 4-azidobutanoic acid | 54447-68-6 | 129.12 | C4 H7 N3 O2 | gamma-azidobutyric acid | >98% | 5 G | 6000 | chiralix |
| CX69359-10G | 4-azidobutyric acid | 4-azidobutanoic acid | 54447-68-6 | 129.12 | C4 H7 N3 O2 | gamma-azidobutyric acid | >98% | 10 G | 11000 | chiralix |
| CX31309-5G | 5-azidovaleric acid | 5-azidopentanoic acid | 79583-98-5 | 143.14 | C5 H9 N3 O2 | delta-azidovaleric acid | >98% | 5 G | 6600 | chiralix |
| CX31309-10G | 5-azidovaleric acid | 5-azidopentanoic acid | 79583-98-5 | 143.14 | C5 H9 N3 O2 | delta-azidovaleric acid | >98% | 10 G | 11800 | chiralix |
| CX98490-5G | 7-azidoheptanoic acid | 7-azidoheptanoic acid | 135920-28-4 | 171.20 | C7 H13 N3 O2 | >98% | 5 G | 6000 | chiralix | |
| CX98490-10G | 7-azidoheptanoic acid | 7-azidoheptanoic acid | 135920-28-4 | 171.20 | C7 H13 N3 O2 | >98% | 10 G | 11000 | chiralix | |
| CX65527-1G | 6-methylcyclohex-1-enecarboxylic acid | 6-methylcyclohex-1-enecarboxylic acid | 5726-56-7 | 140.18 | C8 H12 O2 | >98% | 1 G | 2800 | chiralix | |
| CX65527-5G | 6-methylcyclohex-1-enecarboxylic acid | 6-methylcyclohex-1-enecarboxylic acid | 5726-56-7 | 140.18 | C8 H12 O2 | >98% | 5 G | 10600 | chiralix | |
| CX65527-10G | 6-methylcyclohex-1-enecarboxylic acid | 6-methylcyclohex-1-enecarboxylic acid | 5726-56-7 | 140.18 | C8 H12 O2 | >98% | 10 G | 17000 | chiralix | |
| CX61074-200MG | (S)-beta2-homoalanine HCl salt | (S)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (S)-beta2-hAla-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX61074-500MG | (S)-beta2-homoalanine HCl salt | (S)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (S)-beta2-hAla-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX61074-1G | (S)-beta2-homoalanine HCl salt | (S)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (S)-beta2-hAla-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX39389-200MG | (R)-beta2-homoalanine HCl salt | (R)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (R)-beta2-hAla-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX39389-500MG | (R)-beta2-homoalanine HCl salt | (R)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (R)-beta2-hAla-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX39389-1G | (R)-beta2-homoalanine HCl salt | (R)-3-amino-2-methylpropanoic acid hydrochloride | Not available | 139.58 | C4 H10 Cl N O2 | (R)-beta2-hAla-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX80391-200MG | (R)-beta2-homoleucine HCl salt | (R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (R)-beta2-hLeu-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX80391-500MG | (R)-beta2-homoleucine HCl salt | (R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (R)-beta2-hLeu-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX80391-1G | (R)-beta2-homoleucine HCl salt | (R)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (R)-beta2-hLeu-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX82876-200MG | (R)-beta2-homovaline HCl salt | (R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (R)-beta2-hVal-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX82876-500MG | (R)-beta2-homovaline HCl salt | (R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (R)-beta2-hVal-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX82876-1G | (R)-beta2-homovaline HCl salt | (R)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (R)-beta2-hVal-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX93488-1MG | (±)-sorgolactone | (3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | Not available | 316.35 | C18 H20 O5 | racemic sorgolactone | >98% | 1 MG | 4000 | chiralix |
| CX93488-5MG | (±)-sorgolactone | (3aR*,8S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-8-methyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | Not available | 316.35 | C18 H20 O5 | racemic sorgolactone | >98% | 5 MG | 15000 | chiralix |
| CX64382-1MG | (±)-strigol | (3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | 51820-11-2 | 346.37 | C19 H22 O6 | >98% | 1 MG | 5000 | chiralix | |
| CX64382-5MG | (±)-strigol | (3aR*,5S*,8bS*,2'R*)-3-[(E)-2',5'-dihydro-4'-methyl-5'-oxo-2'-furanyloxymethylene]-5-hydroxy-8,8-dimethyl-3,3a,4,5,6,7,8,8b-octahydroinde,2-b]furan-2-one | 51820-11-2 | 346.37 | C19 H22 O6 | >98% | 5 MG | 18800 | chiralix | |
| CX88057-10MG | Nijmegen-1 | (Z)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate | 159155-03-0 | 343.29 | C17 H13 N O7 | >98% | 10 MG | 3600 | chiralix | |
| CX88057-50MG | Nijmegen-1 | (Z)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-((4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxy)acrylate | 159155-03-0 | 343.29 | C17 H13 N O7 | >98% | 50 MG | 11800 | chiralix | |
| CX42450-200MG | (S)-beta2-homophenylalanine HCl salt | (S)-3-amino-2-benzylpropanoic acid hydrochloride | 1010806-95-7 | 215.68 | C10 H14 Cl N O2 | (S)-beta2-hPhe-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX42450-500MG | (S)-beta2-homophenylalanine HCl salt | (S)-3-amino-2-benzylpropanoic acid hydrochloride | 1010806-95-7 | 215.68 | C10 H14 Cl N O2 | (S)-beta2-hPhe-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX42450-1G | (S)-beta2-homophenylalanine HCl salt | (S)-3-amino-2-benzylpropanoic acid hydrochloride | 1010806-95-7 | 215.68 | C10 H14 Cl N O2 | (S)-beta2-hPhe-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX35419-200MG | (S)-beta2-homovaline HCl salt | (S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (S)-beta2-hVal-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX35419-500MG | (S)-beta2-homovaline HCl salt | (S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (S)-beta2-hVal-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX35419-1G | (S)-beta2-homovaline HCl salt | (S)-2-(aminomethyl)-3-methylbutanoic acid hydrochloride | Not available | 167.63 | C6 H14 Cl N O2 | (S)-beta2-hVal-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX11583-200MG | (R)-beta2-homophenylalanine HCl salt | (R)-3-amino-2-benzylpropanoic acid hydrochloride | Not available | 215.68 | C10 H14 Cl N O2 | (R)-beta2-hPhe-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX11583-500MG | (R)-beta2-homophenylalanine HCl salt | (R)-3-amino-2-benzylpropanoic acid hydrochloride | Not available | 215.68 | C10 H14 Cl N O2 | (R)-beta2-hPhe-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX11583-1G | (R)-beta2-homophenylalanine HCl salt | (R)-3-amino-2-benzylpropanoic acid hydrochloride | Not available | 215.68 | C10 H14 Cl N O2 | (R)-beta2-hPhe-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX92224-200MG | (S)-beta2-homoleucine HCl salt | (S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (S)-beta2-hLeu-OH · HCl | >98% | 200 MG | 4800 | chiralix |
| CX92224-500MG | (S)-beta2-homoleucine HCl salt | (S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (S)-beta2-hLeu-OH · HCl | >98% | 500 MG | 9800 | chiralix |
| CX92224-1G | (S)-beta2-homoleucine HCl salt | (S)-2-(aminomethyl)-4-methylpentanoic acid hydrochloride | Not available | 181.66 | C7 H16 Cl N O2 | (S)-beta2-hLeu-OH · HCl | >98% | 1 G | 16000 | chiralix |
| CX81018-500MG | (S)-Fmoc-beta2-homoalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | 203854-58-4 | 325.36 | C19 H19 N O4 | (S)-Fmoc-beta2-hAla-OH | >98% | 500 MG | 11200 | chiralix |
| CX81018-1G | (S)-Fmoc-beta2-homoalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | 203854-58-4 | 325.36 | C19 H19 N O4 | (S)-Fmoc-beta2-hAla-OH | >98% | 1 G | 18400 | chiralix |
| CX85919-500MG | (R)-Fmoc-beta2-homoalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | Not available | 325.36 | C19 H19 N O4 | (R)-Fmoc-beta2-hAla-OH | >98% | 500 MG | 11200 | chiralix |
| CX85919-1G | (R)-Fmoc-beta2-homoalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid | Not available | 325.36 | C19 H19 N O4 | (R)-Fmoc-beta2-hAla-OH | >98% | 1 G | 18400 | chiralix |
| CX98774-500MG | (R)-Fmoc-beta2-homoleucine | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 1018899-99-4 | 367.44 | C22 H25 N O4 | (R)-Fmoc-beta2-hLeu-OH | >98% | 500 MG | 11200 | chiralix |
| CX98774-1G | (R)-Fmoc-beta2-homoleucine | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 1018899-99-4 | 367.44 | C22 H25 N O4 | (R)-Fmoc-beta2-hLeu-OH | >98% | 1 G | 18400 | chiralix |
| CX33604-500MG | (R)-Fmoc-beta2-homovaline | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | Not available | 353.41 | C21 H23 N O4 | (R)-Fmoc-beta2-hVal-OH | >98% | 500 MG | 11200 | chiralix |
| CX33604-1G | (R)-Fmoc-beta2-homovaline | (R)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | Not available | 353.41 | C21 H23 N O4 | (R)-Fmoc-beta2-hVal-OH | >98% | 1 G | 18400 | chiralix |
| CX82946-500MG | (S)-Fmoc-beta2-homophenylalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 203854-62-0 | 401.45 | C25 H23 N O4 | (S)-Fmoc-beta2-hPhe-OH | >98% | 500 MG | 11200 | chiralix |
| CX82946-1G | (S)-Fmoc-beta2-homophenylalanine | (S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 203854-62-0 | 401.45 | C25 H23 N O4 | (S)-Fmoc-beta2-hPhe-OH | >98% | 1 G | 18400 | chiralix |
| CX86231-500MG | (S)-Fmoc-beta2-homovaline | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | 203854-59-5 | 353.41 | C21 H23 N O4 | (S)-Fmoc-beta2-hVal-OH | >98% | 500 MG | 11200 | chiralix |
| CX86231-1G | (S)-Fmoc-beta2-homovaline | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-3-methylbutanoic acid | 203854-59-5 | 353.41 | C21 H23 N O4 | (S)-Fmoc-beta2-hVal-OH | >98% | 1 G | 18400 | chiralix |
| CX15046-500MG | (R)-Fmoc-beta2-homophenylalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 828254-16-6 | 401.45 | C25 H23 N O4 | (R)-Fmoc-beta2-hPhe-OH | >98% | 500 MG | 11200 | chiralix |
| CX15046-1G | (R)-Fmoc-beta2-homophenylalanine | (R)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | 828254-16-6 | 401.45 | C25 H23 N O4 | (R)-Fmoc-beta2-hPhe-OH | >98% | 1 G | 18400 | chiralix |
| CX30199-500MG | (S)-Fmoc-beta2-homoleucine | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 193887-45-5 | 367.44 | C22 H25 N O4 | (S)-Fmoc-beta2-hLeu-OH | >98% | 500 MG | 11200 | chiralix |
| CX30199-1G | (S)-Fmoc-beta2-homoleucine | (S)-2-(((((9H-fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | 193887-45-5 | 367.44 | C22 H25 N O4 | (S)-Fmoc-beta2-hLeu-OH | >98% | 1 G | 18400 | chiralix |
| CX20422-1ML | cereulide (50 µg/mL in acetonitrile) | cyclo[-Val-D-O-Leu-D-Ala-O-Val-]3 (50 µg/mL in acetonitrile) | Not available | 1153.40 | C57 H96 N6 O18 | cereulide stock solution | >95% | 1 ML | 5000 | chiralix |
| CX87778-1ML | 13C6-cereulide (20 µg/mL in acetonitrile) | cyclo[-Val-1-13C-D-O-Leu-D-Ala-3-13C-O-Val-]3 (20 µg/mL in acetonitrile) | Not available | 1159.36 | C51 13 C6 H96 N6 O18 | 13C6-cereulide stock solution | >95% | 1 ML | 5000 | chiralix |
| CX18112-1G | 4-(azidomethyl)benzoic acid | 4-(azidomethyl)benzoic acid | 79584-03-5 | 177.16 | C8 H7 N3 O2 | >98% | 1 G | 3000 | chiralix | |
| CX18112-5G | 4-(azidomethyl)benzoic acid | 4-(azidomethyl)benzoic acid | 79584-03-5 | 177.16 | C8 H7 N3 O2 | >98% | 5 G | 7400 | chiralix | |
| CX18112-10G | 4-(azidomethyl)benzoic acid | 4-(azidomethyl)benzoic acid | 79584-03-5 | 177.16 | C8 H7 N3 O2 | >98% | 10 G | 13200 | chiralix | |
| CX95981-5G | 2,2,2-trichloroethoxysulfonyl chloride | 2,2,2-trichloroethoxysulfonyl chloride | 764-09-0 | 247.91 | C2 H2 Cl4 O2 S | chlorosulfuric acid 2,2,2-trichloroethyl ester | >98% | 5 G | 2200 | chiralix |
| CX95981-10G | 2,2,2-trichloroethoxysulfonyl chloride | 2,2,2-trichloroethoxysulfonyl chloride | 764-09-0 | 247.91 | C2 H2 Cl4 O2 S | chlorosulfuric acid 2,2,2-trichloroethyl ester | >98% | 10 G | 4000 | chiralix |
| CX95981-25G | 2,2,2-trichloroethoxysulfonyl chloride | 2,2,2-trichloroethoxysulfonyl chloride | 764-09-0 | 247.91 | C2 H2 Cl4 O2 S | chlorosulfuric acid 2,2,2-trichloroethyl ester | >98% | 25 G | 8400 | chiralix |
| CX62483-1G | 2-(azidomethyl)benzoic acid | 2-(azidomethyl)benzoic acid | 289712-57-8 | 177.16 | C8 H7 N3 O2 | >98% | 1 G | 4200 | chiralix | |
| CX62483-2G | 2-(azidomethyl)benzoic acid | 2-(azidomethyl)benzoic acid | 289712-57-8 | 177.16 | C8 H7 N3 O2 | >98% | 2 G | 7600 | chiralix | |
| CX62483-5G | 2-(azidomethyl)benzoic acid | 2-(azidomethyl)benzoic acid | 289712-57-8 | 177.16 | C8 H7 N3 O2 | >98% | 5 G | 16000 | chiralix | |
| CX80461-1G | 3-(azidomethyl)benzoic acid | 3-(azidomethyl)benzoic acid | 905973-32-2 | 177.16 | C8 H7 N3 O2 | >98% | 1 G | 4200 | chiralix | |
| CX80461-2G | 3-(azidomethyl)benzoic acid | 3-(azidomethyl)benzoic acid | 905973-32-2 | 177.16 | C8 H7 N3 O2 | >98% | 2 G | 7600 | chiralix | |
| CX80461-5G | 3-(azidomethyl)benzoic acid | 3-(azidomethyl)benzoic acid | 905973-32-2 | 177.16 | C8 H7 N3 O2 | >98% | 5 G | 16000 | chiralix | |
| CX27597-1G | 2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazolium triflate | 2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-ium trifluoromethanesulfonate | 1185733-70-3 | 457.66 | C8 H10 Cl3 F3 N2 O6 S2 | >98% | 1 G | 2600 | chiralix | |
| CX27597-5G | 2,3-dimethyl-1-(2,2,2-trichloroethoxysulfuryl)imidazolium triflate | 2,3-dimethyl-1-((2,2,2-trichloroethoxy)sulfonyl)-1H-imidazol-3-ium trifluoromethanesulfonate | 1185733-70-3 | 457.66 | C8 H10 Cl3 F3 N2 O6 S2 | >98% | 5 G | 9800 | chiralix | |
| CX50506-10MG | TIS108 | 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one | Not available | 335.40 | C20 H21 N3 O2 | >98% | 10 MG | 3600 | chiralix | |
| CX50506-50MG | TIS108 | 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one | Not available | 335.40 | C20 H21 N3 O2 | >98% | 50 MG | 13800 | chiralix | |
| CX50506-100MG | TIS108 | 6-phenoxy-1-phenyl-2-(1H-1,2,4-triazol-1-yl)hexan-1-one | Not available | 335.40 | C20 H21 N3 O2 | >98% | 100 MG | 23000 | chiralix | |
| CX95469-10MG | 4-Br debranone | 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one | 1332863-94-1 | 269.09 | C11 H9 Br O3 | 4BD | >98% | 10 MG | 3000 | chiralix |
| CX95469-50MG | 4-Br debranone | 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one | 1332863-94-1 | 269.09 | C11 H9 Br O3 | 4BD | >98% | 50 MG | 11400 | chiralix |
| CX95469-100MG | 4-Br debranone | 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one | 1332863-94-1 | 269.09 | C11 H9 Br O3 | 4BD | >98% | 100 MG | 19600 | chiralix |
| CX75854-10MG | 4-CN debranone | 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one | 1332863-97-4 | 215.20 | C12 H9 N O3 | >98% | 10 MG | 3000 | chiralix | |
| CX75854-50MG | 4-CN debranone | 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one | 1332863-97-4 | 215.20 | C12 H9 N O3 | >98% | 50 MG | 11400 | chiralix | |
| CX75854-100MG | 4-CN debranone | 5-(4-cyanophenoxy)-3-methylfuran-2(5H)-one | 1332863-97-4 | 215.20 | C12 H9 N O3 | >98% | 100 MG | 19600 | chiralix | |
| CX52612-10MG | Abamine oxalic acid salt | (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate | Not available | 463.45 | C23 H26 F N O8 | >98% | 10 MG | 3000 | chiralix | |
| CX52612-50MG | Abamine oxalic acid salt | (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate | Not available | 463.45 | C23 H26 F N O8 | >98% | 50 MG | 11400 | chiralix | |
| CX52612-100MG | Abamine oxalic acid salt | (E)-3-(3,4-dimethoxyphenyl)-N-(4-fluorobenzyl)-N-(2-methoxy-2-oxoethyl)prop-2-en-1-aminium carboxyformate | Not available | 463.45 | C23 H26 F N O8 | >98% | 100 MG | 19600 | chiralix | |
| CX93797-10G | Fmoc-D-cyclohexylglycine | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 198543-96-3 | 379.45 | C23 H25 N O4 | Fmoc-D-Chg-OH | >97% | 10 G | 6000 | chiralix |
| CX93797-25G | Fmoc-D-cyclohexylglycine | (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 198543-96-3 | 379.45 | C23 H25 N O4 | Fmoc-D-Chg-OH | >97% | 25 G | 13000 | chiralix |
| CX29693-10G | Fmoc-L-cyclohexylglycine | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 161321-36-4 | 379.45 | C23 H25 N O4 | Fmoc-L-Chg-OH | >97% | 10 G | 6000 | chiralix |
| CX29693-25G | Fmoc-L-cyclohexylglycine | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid | 161321-36-4 | 379.45 | C23 H25 N O4 | Fmoc-L-Chg-OH | >97% | 25 G | 13000 | chiralix |
公司主要产品：
1、氨基酸类：包括各种以氨基酸为骨架的手性衍生物。
2、N-BOC保护的氨基酸骨架类
3、N-CBZ 保护的氨基酸骨架类
4、N-FMOC 保护的氨基酸骨架类
5、AZIDO氨基酸骨架类
6、β2氨基酸骨架类
7、FMOC保护的β2氨基酸骨架类
8、CHROMOGENIC 及FLUOROGENIC氨基酸
9、氨基乙醇及其衍生产品
10、CEREULIDE & 13C6-CEREULIDE（致吐毒素及其衍生品）
11、STRIGOLACTONES & ANALOGUES（独脚金内酯及其类似物）
12、其它产品
更多产品请访问：http://www.chiralix.com/
世界*实验材料供应商Chiralix正式上海金畔为其中国代理，Chiralix在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔一直秉承为中国科研客户带来的产品，的服务， Chiralix就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获
Chiralix中国代理，Chiralix上海代理，Chiralix北京代理，Chiralix广东代理，Chiralix江苏代理 Chiralix湖北代理, Chiralix天津, Chiralix黑龙江代理, Chiralix内蒙古代理, Chiralix吉林代理, Chiralix福建代理, Chiralix江苏代理, Chiralix浙江代理, Chiralix四川代理,
我们公司zui大优势是强大的采购，
1：基本什么都能进口，血清，抗体，耗材，还有部分限制进口的，
2： 货品全，现经营过700多个品牌，基本所有生物试剂耗材都可以进口，特别是冷偏的产品那就更有优势，
3：提供加急服务，一般1-2周到货，超过时限加急费全免
4：价格公道，绝大部分价格有优势，当然不能保证100%产品都是,因为意味着没有服务.
5：良好的信誉，大部分客户我们提供货到付款服务，客户包括清华，北大 交大 复旦，中山等100多所大学，ROCHE，阿斯利康，国药 ，fisher等500多家公司
6：我们还是santa,Advanced Biotechnologies Inc;Athens Research & Technology, bangs, BBInternational, crystalchem, dianova, FD Neurotechnologies, Inc. FormuMax Scientific, Inc; Genebridege; Glycotope Biotechnology GmbH; iduron; Innovative Research of America； Ludger ； neuroprobe; omicronbio; Polysciences; prospecbi; QA-BIO；quickzyme；RESEARCH DIETS, INC；sterlitech；sysy；TriLink BioTechnologies, Inc；worthington-biochem;zyagen;……几十家国外公司代理
7：我们还从事invitrogen，qiagen; abcam ;sigma;neb; roche;merck; rnd; BD; GE; pierce; BioLegend….等*批发